These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 17951320)

  • 21. Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model.
    Choi B; Hwang Y; Kwon HJ; Lee ES; Park KS; Bang D; Lee S; Sohn S
    J Dermatol Sci; 2008 Nov; 52(2):87-97. PubMed ID: 18585901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis.
    Yamada S; Ding Y; Tanimoto A; Wang KY; Guo X; Li Z; Tasaki T; Nabesima A; Murata Y; Shimajiri S; Kohno K; Ichijo H; Sasaguri Y
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1555-64. PubMed ID: 21527753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice.
    Gourdy P; Schambourg A; Filipe C; Douin-Echinard V; Garmy-Susini B; Calippe B; Tercé F; Bayard F; Arnal JF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2214-21. PubMed ID: 17690314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.
    Li K; Ching D; Luk FS; Raffai RL
    Circ Res; 2015 Jun; 117(1):e1-e11. PubMed ID: 25904598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary diacylglycerol extenuates arterial thrombosis in apoE and LDLR deficient mice.
    Ijiri Y; Naemura A; Yamashita T; Meguro S; Watanabe H; Tokimitsu I; Yamamoto J
    Thromb Res; 2006; 117(4):411-7. PubMed ID: 15885757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level.
    Wang KY; Tanimoto A; Guo X; Yamada S; Shimajiri S; Murata Y; Ding Y; Tsutsui M; Kato S; Watanabe T; Ohtsu H; Hirano K; Kohno K; Sasaguri Y
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):800-7. PubMed ID: 21273563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E suppresses the type I inflammatory response in vivo.
    Ali K; Middleton M; Puré E; Rader DJ
    Circ Res; 2005 Oct; 97(9):922-7. PubMed ID: 16179587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
    Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE; Li X; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2003 Aug; 42(33):9841-53. PubMed ID: 12924933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
    Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F; Lombardo E; van Roomen CP; Ottenhoff R; Vos M; Rensen PC; Verhoeven AJ; Aerts JM; Groen AK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
    Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
    Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ; Chan L
    Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction precedes atherosclerotic lesions and platelet activation in high fat diet-induced prothrombotic state.
    Aoki R; Ikarugi H; Naemura A; Ijiri Y; Yamashita T; Yamamoto J
    Thromb Res; 2006; 117(5):529-35. PubMed ID: 15916796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.
    Whitman SC; Rateri DL; Szilvassy SJ; Yokoyama W; Daugherty A
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1049-54. PubMed ID: 14988092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
    Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.